Brentuximab Vedotin plus Chemotherapy in High Risk Advanced-Stage Hodgkin Lymphoma (HL) Patients: Results of Pre-Specified Sub-group Analyses from the ECHELON-1 Study
Research output: Contribution to conference › Abstract
Fingerprint
Dive into the research topics of 'Brentuximab Vedotin plus Chemotherapy in High Risk Advanced-Stage Hodgkin Lymphoma (HL) Patients: Results of Pre-Specified Sub-group Analyses from the ECHELON-1 Study'. Together they form a unique fingerprint.